Toric IOL improves patient quality of life

Article

Implantation of a toric IOL results in improved patient quality of life and better visual, refractive and aberrometric results, states a new investigation.

Implantation of a toric IOL results in improved patient quality of life and better visual, refractive and aberrometric results, states a new investigation.

A team headed by Dr R. Mencucci, Department of Specialised Surgical Sciences–Eye Clinic, University of Florence, Florence, Italy, assessed three groups of subjects who underwent unilateral cataract surgery with IOL implantation.

The first group consisted of 40 patients with corneal astigmatism greater than 1.5 D implanted with an Acysof toric SN60TT IOL. Group two included 40 astigmatic patients implanted with the SN60AT IOL and group three included 40 patients with an astigmatism of less than 1.00 D implanted with an SB60AT IOL.

The outcome measures were uncorrected distance visual acuity (UDVA), refraction, lower order astigmatism, Strehl ratio and the modulation transfer function area ratio assessed over a three-month follow-up period. The group used a standardised quality of life test to assess both astigmatic groups three months postoperatively.

Postoperative UDVA and aberrometric values were significantly better in the toric and control group, compared with the SN60AT group. The mean postoperative spherical equivalent was significantly lower in the toric and control groups, compared to the SN60AT group.

Overall, the toric lens resulted in a better postoperative quality of life compared to the astigmatic SN60AT lens in astigmatic patients.

Please visit the British Journal of Ophthalmology to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.